ESR1 and hepatocellular carcinoma: On the other hand, four ER+ cell lines with mutant TP53, HCC-1954, CAMA1, SK-BR-3, and BT-474, showed resistance to ALRN-6924 with average IC50 over 30 μM (Fig. 1d).